Business Description
Delta-Fly Pharma Inc
ISIN : JP3549370009
Share Class Description:
TSE:4598: Ordinary SharesDescription
Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.74 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -1.5 | |||||
| 3-Year EPS without NRI Growth Rate | -2 | |||||
| 3-Year FCF Growth Rate | -4.1 | |||||
| 3-Year Book Growth Rate | -27.4 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.38 | |||||
| 9-Day RSI | 39.05 | |||||
| 14-Day RSI | 44.83 | |||||
| 6-1 Month Momentum % | -10.64 | |||||
| 12-1 Month Momentum % | -44.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.49 | |||||
| Quick Ratio | 3.49 | |||||
| Cash Ratio | 3.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -157.07 | |||||
| ROA % | -137.08 | |||||
| ROIC % | -3225.03 | |||||
| ROC (Joel Greenblatt) % | -3688.16 | |||||
| ROCE % | -154.22 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 15.18 | |||||
| Price-to-Tangible-Book | 14.87 | |||||
| EV-to-EBIT | -3.08 | |||||
| EV-to-EBITDA | -3.08 | |||||
| EV-to-FCF | -3.86 | |||||
| Price-to-Net-Current-Asset-Value | 17.05 | |||||
| Price-to-Net-Cash | 19.64 | |||||
| Earnings Yield (Greenblatt) % | -32.37 | |||||
| FCF Yield % | -24.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Delta-Fly Pharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | |||
| EPS (TTM) (円) | -198.78 | ||
| Beta | -1.75 | ||
| Volatility % | 44.94 | ||
| 14-Day RSI | 44.83 | ||
| 14-Day ATR (円) | 48.842417 | ||
| 20-Day SMA (円) | 605.45 | ||
| 12-1 Month Momentum % | -44.37 | ||
| 52-Week Range (円) | 445 - 1078 | ||
| Shares Outstanding (Mil) | 9.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Delta-Fly Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Delta-Fly Pharma Inc Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Delta-Fly Pharma Inc Frequently Asked Questions
What is Delta-Fly Pharma Inc(TSE:4598)'s stock price today?
The current price of TSE:4598 is 円570.00. The 52 week high of TSE:4598 is 円1078.00 and 52 week low is 円445.00.
When is next earnings date of Delta-Fly Pharma Inc(TSE:4598)?
The next earnings date of Delta-Fly Pharma Inc(TSE:4598) is .
Does Delta-Fly Pharma Inc(TSE:4598) pay dividends? If so, how much?
Delta-Fly Pharma Inc(TSE:4598) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers